Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-25T08:23:45.525Z Has data issue: false hasContentIssue false

7 - Medical Issues in Older Adults with Schizophrenia

from Section 2 - Biological, Neurocognitive, and Medical Aspects

Published online by Cambridge University Press:  15 March 2019

By
Frank Copeli  and
Carl I. Cohen
Edited by
Carl I. Cohen  and
Paul D. Meesters
Carl I. Cohen
Affiliation:
SUNY Downstate Medical Center
Paul D. Meesters
Affiliation:
Friesland Mental Health Services
Get access

Summary

This chapter reviews epidemiological findings concerning medical comorbidity and mortality in older adults with schizophrenia (OAS). Several key points emerged from this review: (1) There are inconsistencies in the prevalence of various medical disorders among OAS. (2) There is a 2.0 to 2.5 times increase in all-cause mortality in OAS compared to their age peers, although it is lower than their younger counterparts. (3) The risk of suicide trends downward in OAS patients after the age of 60. (4) A higher prevalence of respiratory diseases has not been demonstrated consistently; however, there is increased mortality for respiratory disease versus age peers, but reduced compared to younger counterparts. (5) There has been no demonstrated increase in mortality or prevalence of diabetes in OAS versus age peers. (6) OAS have declining mortality rates from cardiovascular disease compared to younger counterparts, but still elevated compared to age peers. (7) There have been inconsistent findings regarding the incidence of cancer compared to age peers; however, the cancer mortality rate is higher. (8) A healthcare utilization gap exists for OAS. Novel care strategies include self-management, peer support groups, integrated care models, and greater use of telehealth and mobile technologies.
Type
Chapter
Information
Schizophrenia and Psychoses in Later Life
New Perspectives on Treatment, Research, and Policy
 , pp. 79 - 94
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hendrie, HC, Tu, W, Tabbey, R, et al. Health outcomes and cost of care among older adults with schizophrenia: a 10-year study using medical records across the continuum of care. Am J Geriatr Psychiatry 2014; 22(5): 427–36.CrossRefGoogle ScholarPubMed
Brink, M, Green, A, Bojesen, AB, et al. Physical health, medication, and healthcare utilization among 70–year–old people with schizophrenia: a nationwide Danish register study. Am J Geriatr Psychiatry 2017; 25: 500–9.CrossRefGoogle ScholarPubMed
Talaslahti, T, Alanen, H-M, Hakko, H, et al. Mortality and causes of death in older patients with schizophrenia. Int J Geriatr Psychiatry 2012; 27: 1131–7.CrossRefGoogle ScholarPubMed
Laursen, TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 2011; 131(1–3): 101–4.CrossRefGoogle ScholarPubMed
Hjorthøj, C, Stürup, AE, Mcgrath, JJ, Nordentoft, M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry 2017; 4(4): 295–301.CrossRefGoogle ScholarPubMed
Saha, S, Chant, D, McGrath, J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123–31.CrossRefGoogle ScholarPubMed
Cohen, CI, Freeman, K, Ghoneim, D, et al. Advances in the conceptualization and study of schizophrenia in later life. Psychiatr Clin N Am 2018; 41: 39–53.CrossRefGoogle ScholarPubMed
Almeida, OP, Hankey, GJ, Yeap, BB, et al. Mortality among people with severe mental disorders who reach old age: a longitudinal study of a community-representative sample of 37892 men. PloS one 2014; 9(10): e111882.CrossRefGoogle ScholarPubMed
Meesters, PD, Comijs, HC, Smit, JH, et al. Mortality and its determinants in late-life schizophrenia: a 5-year prospective study in a Dutch catchment area. Am J Geriatr Psychiatry 2016; 24: 272–7.CrossRefGoogle Scholar
Hoang, U, Stewart, R, Goldacre, MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999–2006. BMJ 2011; 343: d5422.CrossRefGoogle ScholarPubMed
Erlangsen, A, Eaton, WW, Mortensen, PB, Conwell, Y. Schizophrenia: a predictor of suicide during the second half of life? Schizophr Res 2012; 134(2–3): 111–17.CrossRefGoogle ScholarPubMed
Chang, CK, Hayes, RD, Broadbent, M, et al. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry 2010; 10: 77.CrossRefGoogle ScholarPubMed
Meesters, PD. Healthy older schizophrenia patients: exceptions to the rule? Am J Geriatr Psychiatry 2017; 25(5): 510–11.CrossRefGoogle ScholarPubMed
Crump, C, Winkleby, MA, Sundquist, K, Sundquist, J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 2013; 170(3): 324–33.CrossRefGoogle ScholarPubMed
Partti, K, Vasankari, T, Kanervisto, M, et al. Lung function and respiratory diseases in people with psychosis: population-based study. Br J Psychiatry 2015; 207(1): 37–45.CrossRefGoogle ScholarPubMed
Kredentser, MS, Martens, PJ, Chochinov, HM, Prior, HJ. Cause and rate of death in people with schizophrenia across the lifespan: a population-based study in Manitoba, Canada. J Clin Psychiatry 2012; 74: 154–61.Google Scholar
Talaslahti, T, Alanen, HM, Hakko, H, et al. Patients with very‐late‐onset schizophrenia‐like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia. Int J Geriatr Psychiatry 2015; 30(5): 453–9.CrossRefGoogle ScholarPubMed
Hsu, J-H, Chien, IC, Lin, CH, Chou, YJ, Chou, P. Increased risk of chronic obstructive pulmonary disease in patients with schizophrenia: a population-based study. Psychosomatics 2013; 54(4): 345–51.CrossRefGoogle ScholarPubMed
Schoepf, D, Uppal, H, Potluri, R, Heun, R. Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci 2014; 264(1): 3–28.CrossRefGoogle ScholarPubMed
Bouza, C, López-Cuadrado, T, María Amate, J. Physical disease in schizophrenia: a population-based analysis in Spain. BMC Publ Health 2010; 10(1): 745.CrossRefGoogle ScholarPubMed
Cahoon, EK, McGinty, EE, Ford, DE, Daumit, GL. Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study. BMC Psychiatry 2013; 13(1): 37.CrossRefGoogle ScholarPubMed
Olfson, M, Gerhard, T, Huang, C, Crystal, S, Stroup, TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 2015; 72(12): 1172–81.CrossRefGoogle ScholarPubMed
Chen, Y-H, Lin, H-C, Lin, H-C. Poor clinical outcomes among pneumonia patients with schizophrenia. Schizophr Bull 2010; 37(5): 1088–94.Google ScholarPubMed
Chou, FH-C, Tsai, K-Y, Chou, Y-M. The incidence and all-cause mortality of pneumonia in patients with schizophrenia: a nine-year follow-up study. J Psychiatr Res 2013; 47(4): 460–6.CrossRefGoogle ScholarPubMed
U.S. Food and Drug Administration. Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioural Disturbances. Silver Spring, MD: U.S. Food and Drug Administration; 2005.Google Scholar
Trifirò, G, Gambassi, G, Sen, EF, et al. Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study. Ann Intern Med 2010; 152: 418–25.CrossRefGoogle ScholarPubMed
Knol, W, Marum, RJ, Jansen, PA, et al. Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc 2008; 56: 661–6.CrossRefGoogle ScholarPubMed
Gau, JT, Acharya, U, Khan, S, et al. Pharmacotherapy and the risk for community-acquired pneumonia. BMC Geriatr 2010; 10: 45.CrossRefGoogle ScholarPubMed
Star, K, Bate, A, Meyboom, RH, Edwards, IR. Pneumonia following antipsychotic prescriptions in electronic health records: a patient safety concern? Br J Gen Pract 2010; 60: e385–94.CrossRefGoogle ScholarPubMed
Barnett, MJ, Perry, PJ, Alexander, B, Kaboli, PJ. Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients. J Clin Psychopharmacol 2006; 26: 182–7.CrossRefGoogle ScholarPubMed
Kuo, C-J, Yang, S-Y, Liao, Y-T, et al. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophr Bull 2013; 39(3): 648–57.CrossRefGoogle ScholarPubMed
Trifirò, G. Antipsychotic drug use and community-acquired pneumonia. Curr Infect Disease Rep 2011; 13(3): 262–8.Google ScholarPubMed
Correll, CU, Detraux, J, De Lepeleire, J, De Hert, M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015; 14(2): 119–36.CrossRefGoogle ScholarPubMed
Vahia, IV, Diwan, S, Bankole, AO, et al. Adequacy of medical treatment among older persons with schizophrenia. Psychiatr Serv 2008; 59: 853–9.CrossRefGoogle ScholarPubMed
Kilbourne, AM, Brar, JS, Drayer, RA, Xu, X, Post, EP. Cardiovascular disease and metabolic risk factors in male patients with schizophrenia, schizoaffective disorder, and bipolar disorder. Psychosomatics 2007; 48(5): 412–17.CrossRefGoogle ScholarPubMed
Sajatovic, M, Gunzler, D, Einstadter, D, et al. A preliminary analysis of individuals with serious mental illness and comorbid diabetes. Arch Psychiatr Nurs 2016; 30(2): 226–9.CrossRefGoogle ScholarPubMed
Osborn, DPJ, Levy, G, Nazareth, I, Petersen, I, Islam, A, King, MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry 2007; 64(2): 242–9.CrossRefGoogle Scholar
Casey, DA, Rodriguez, M, Northcott, C, Vickar, G, Shihabuddin, L. Schizophrenia: medical illness, mortality, and aging. Int J Psychiatry Med 2011; 41(3): 245–51.CrossRefGoogle ScholarPubMed
Martens, PJ, Chochinov, HM, Prior, HJ. Where and how people with schizophrenia die: a population-based, matched cohort study in Manitoba, Canada. J Clin Psychiatry 2013; 74(6): e551–7.CrossRefGoogle Scholar
Jeste, DV, Wolkowitz, OM, Palmer, BW. Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophr Bull 2011; 37(3): 451–5.CrossRefGoogle ScholarPubMed
Bresee, LC, Majumdar, SR, Patten, SB, et al. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res 2010; 117: 75–82.CrossRefGoogle ScholarPubMed
Hahn, LA, Mackinnon, A, Foley, DL, et al. The value of counting WHO-defined cardiovascular risk factors for death and disability in a national sample of adults with psychosis. Schizophr Res 2017; 182: 13–18.CrossRefGoogle Scholar
Fors, BM, Isacson, D, Bingefors, K, Widerlov, B. Mortality among persons with schizophrenia in Sweden: an epidemiological study. Nord J Psychiatry 2007; 61(4): 252–9.CrossRefGoogle ScholarPubMed
Goff, DC, Cather, C, Evins, AE, et al. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry 2005; 66(2): 183–94.CrossRefGoogle ScholarPubMed
Olfson, M, Gerhard, T, Huang, C, Crystal, S, Stroup, TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 2015; 72(12): 1172–81.CrossRefGoogle ScholarPubMed
Ösby, U, Westman, J, Hällgren, J, Gissler, M. Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987–2010. Eur J Publ Health 2016; 26(5): 867–71.CrossRefGoogle ScholarPubMed
Schulman-Marcus, J, Goyal, P, Swaminathan, RV, et al. Comparison of trends in incidence, revascularization, and in-hospital mortality in ST-elevation myocardial infarction in patients with versus without severe mental illness. Am J Cardiol 2016; 117(9): 1405–10.CrossRefGoogle ScholarPubMed
Bodén, R, Molin, E, Jernberg, T, et al. Higher mortality after myocardial infarction in patients with severe mental illness: a nationwide cohort study. J Intern Med 2015; 277(6): 727–36.CrossRefGoogle ScholarPubMed
Viñas, CL, Fernández San-Martín, MI, Martín López, LM. Effectiveness of a joint project between primary care and mental health to improve the recording of cardiovascular risk factors in patients with psychosis. Aten Primaria 2012; 45(6): 307–14.Google Scholar
Rouillon, F, Van Ganse, E, Vekhoff, P, et al. Vigilance level for cardiovascular risk factors in schizophrenic patients. L'Encephale 2015; 41(1): 70–7.Google ScholarPubMed
Daumit, GL, Goff, DC, Meyer, JM, et al. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res 2008; 105(1–3): 174–87.CrossRefGoogle ScholarPubMed
Torniainen, M, Mittendorfer-Rutz, E, Tanskanen, A, et al. Antipsychotic treatment and mortality in schizophrenia. Schizophr Bull 2015; 41(3): 656–63.CrossRefGoogle ScholarPubMed
Zhou, C, Tao, R, Jiang, R, Lin, X, Shao, M. Cancer mortality in patients with schizophrenia: systematic review and meta-analysis. Br J Psychiatry 2017; 211(1): 7–13.CrossRefGoogle Scholar
Talaslahti, T. Finnish older patients with schizophrenia: antipsychotic use, psychiatric admissions, long-term care and mortality. Dissertation, University of Tampere, 2015.Google Scholar
Kelly, DL, McMahon, RP, Wehring, HJ, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull 2011; 37(4): 832–8.CrossRefGoogle ScholarPubMed
Das-Munshi, J, Chang, CK, Dutta, R, et al. Ethnicity and excess mortality in severe mental illness: a cohort study. Lancet Psychiatry 2017; 4(5): 389–99.Google ScholarPubMed
Kisely, S, Sadek, J, Mackenzie, A, Lawrence, D, Campbell, LA. Excess cancer mortality in psychiatric patients. Can J Psychiatry 2008; 53: 753–61.CrossRefGoogle ScholarPubMed
Kisely, S, Crowe, E, Lawrence, D. Cancer-related mortality in people with mental illness. JAMA Psychiatry 2013; 70(2): 209–17.CrossRefGoogle ScholarPubMed
Lawrence, D, Holman, CD, Jablensky, AV, Threlfall, TJ, Fuller, SA. Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr Scand 2000; 101(5): 382–8.CrossRefGoogle ScholarPubMed
Bushe, CJ, Hodgson, R. Schizophrenia and cancer: in 2010 do we understand the connection? Can J Psychiatry 2010; 55(12): 761–7.CrossRefGoogle ScholarPubMed
Goldacre, MJ, Kurina, LM, Wotton, CJ, Yeates, D, Seagroat, V. Schizophrenia and cancer: an epidemiological study. Br J Psychiatry 2005; 187: 334–8.CrossRefGoogle ScholarPubMed
Chen, LY, Hung, YN, Chen, YY, et al. Cancer incidence in young and middle-aged people with schizophrenia: nationwide cohort study in Taiwan, 2000–2010. Epidemiol Psychiatr Sci 2018; 27(2): 146–56.CrossRefGoogle Scholar
Lin, G-M, Chen, YJ, Kuo, DJ, et al. Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997–2009. Schizophr Bull 2013; 39(2): 407–16.CrossRefGoogle ScholarPubMed
Kisely, S, Forsyth, S, Lawrence, D. Why do psychiatric patients have higher cancer mortality rates when cancer incidence is the same or lower? Aus NZ J Psychiatry 2016; 50(3): 254–63.CrossRefGoogle ScholarPubMed
Lin, C‐Y, Lane, HY, Chen, TT, et al. Inverse association between cancer risks and age in schizophrenic patients: a 12‐year nationwide cohort study. Cancer Sci 2013; 104(3): 383–90.CrossRefGoogle ScholarPubMed
Bergamo, C, Sigel, K, Mhango, G, Kale, M, Wisnivesky, JP. Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study. Psychosom Med 2014; 76(3): 215.CrossRefGoogle ScholarPubMed
Baillargeon, J, Kuo, YF, Lin, YL, et al. Effect of mental disorders on diagnosis, treatment, and survival of older adults with colon cancer. J Am Geriatr Soc 2011; 59(7): 1268–73.CrossRefGoogle ScholarPubMed
Werneke, U, Horn, O, Maryon-Davis, A, et al. Uptake of screening for breast cancer in patients with mental health problems. J Epidemiol Community Health 2006; 60(7): 600–5.CrossRefGoogle ScholarPubMed
Irwin, KE, Henderson, DC, Knight, HP, Pirl, WF. Cancer care for individuals with schizophrenia. Cancer 2014; 120(3): 323–34.CrossRefGoogle ScholarPubMed
Aggarwal, A, Pandurangi, A, Smith, W. Disparities in breast and cervical cancer screening in women with mental illness: a systematic literature review. Am J Prev Med 2013; 44(4): 392–8.CrossRefGoogle ScholarPubMed
Chochinov, H, Martena, PJ, Prior, HJ, Fransoo, R, Burland, E. Does a diagnosis of schizophrenia reduce rates of mammography screening? A Manitoba population-based study. Schizophr Res 2009; 113: 95–100.CrossRefGoogle ScholarPubMed
Xiong, G, Bermudes, R, Torres, S, Hales, R. Use of cancer screening services among patients with serious mental illness in Sacramento County. Psychiatr Serv 2008; 59: 929–32.CrossRefGoogle Scholar
Martens, PJ, Chochinov, HM, Prior, HJ, et al. Are cervical cancer screening rates different for women with schizophrenia? A Manitoba population-based study. Schizophr Res 2009; 113(1): 101–6.CrossRefGoogle ScholarPubMed
Crump, C, Winkleby, MA, Sundquist, K, Sundquist, J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 2013; 170: 324–33.CrossRefGoogle ScholarPubMed
De Hert, M, Peuskens, J, Sabbe, T, et al. Relationship between prolactin, breast cancer risk and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatr Scand 2016; 133(1): 5–22.CrossRefGoogle ScholarPubMed
Andrews, AO, Bartels, SJ, Xie, H, et al. Increased risk of nursing home admission among middle aged and older adults with schizophrenia. Am J Geriatr Psychiatry 2009; 17(8): 697–705.CrossRefGoogle ScholarPubMed
Horan, ME, Muller, JJ, Winocur, S, et al. Quality of life in boarding houses and hostels: a residents’ perspective. Community Ment Health J 2001; 37(4): 323–34.CrossRefGoogle ScholarPubMed
Davis, CL, Kilbourne, AM, Blow, FC, et al. Reduced mortality among Department of Veterans Affairs patients with schizophrenia or bipolar disorder lost to follow-up and engaged in active outreach to return for care. Am J Publ Health 2012; 102(Suppl 1): S74–9.CrossRefGoogle ScholarPubMed
Ganzini, L, Socherman, R, Duckart, J, Shores, M. End-of-life care for veterans with schizophrenia and cancer. Psychiatr Serv 2010; 61: 725–8.CrossRefGoogle ScholarPubMed
Bartels, SJ, DiMilia, PR, Fortuna, KL, Naslund, JA. Integrated care for older adults with serious mental illness and medical comorbidity: evidence-based models and future research directions. Psychiatr Clin N Am 2018; 41(1): 153–64.CrossRefGoogle ScholarPubMed
Druss, BG, Rohrbaugh, RM, Levinson, CM, et al. Integrated medical care for patients with serious psychiatric illness: a randomized trial. Arch Gen Psychiatry 2001; 58(9): 861–8.CrossRefGoogle ScholarPubMed
Saxon, AJ, Malte, CA, Sloan, KL, et al. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment. Med Care 2006; 44(4): 334–42.CrossRefGoogle ScholarPubMed
Druss, BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry 2007; 68(Suppl 4): 40–4.Google ScholarPubMed
Druss, BG, von Esenwein, SA, Compton, MT, et al. A randomized trial of medical care management for community mental health settings: the primary care access, referral, and evaluation (PCARE) study. Am J Psychiatry 2010; 167(2): 151–9.CrossRefGoogle ScholarPubMed
Druss, BG, von Esenwein, SA, Glick, GE, et al. Randomized trial of an integrated behavioral health home: the health outcomes management and evaluation (HOME) study. Am J Psychiatry 2017; 174(3): 246–55.CrossRefGoogle ScholarPubMed
Pirraglia, PA, Rowland, E, Wu, W-C, et al. Benefits of a primary care clinic co-located and integrated in a mental health setting for veterans with serious mental illness. Prev Chronic Dis 2012; 9: E51.Google Scholar
Pratt, SI, Bartels, SJ, Mueser, KT, et al. Feasibility and effectiveness of an automated telehealth intervention to improve illness self-management in people with serious psychiatric and medical disorders. Psychiatr Rehabil J 2013; 36(4): 297–305.CrossRefGoogle ScholarPubMed
Fortuna, KL, Dimilia, PR, Lohman, MC, et al. Feasibility, acceptability, and preliminary effectiveness of a peer-delivered and technology supported self-management intervention for older adults with serious mental illness. Psychiatr Q. 2018; 89(2): 293–305.CrossRefGoogle ScholarPubMed
Naslund, JA, Aschbrenner, KA, Bartels, SJ. How people living with serious mental illness use smartphones, mobile apps, and social media. Psychiatr Rehabil J 2016; 39(4): 364–7.CrossRefGoogle Scholar
Naslund, JA, Aschbrenner, KA, Marsch, LA, et al. The future of mental health care: peer-to-peer support and social media. Epidemiol Psychiatr Sci 2016; 25(2): 113–22.CrossRefGoogle ScholarPubMed
Naslund, JA, Aschbrenner, KA, McHugo, GJ, et al. Exploring opportunities to support mental health care using social media: a survey of social media users with mental illness. Early Interv Psychiatry 2017: 1–9. doi: 10.1111/eip.12496. [Epub ahead of print]Google ScholarPubMed
Fortuna, KL, Lohman, MC, Batsis, JA, et al. Patient experience with healthcare services among older adults with serious mental illness compared to the general older population. Int J Psychiatry Med 2017; 52(4-6): 381–98.CrossRefGoogle Scholar
De Hert, M, Cohen, D, Bobes, J, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 2011; 10(2): 138–51.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×